• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
OBSV

OBSV

ObsEva S.A.

NASDAQHealthcareBiotechnologyCH

USD0.10

+0.00 (+0.00%)

Company Profile

CEO

William Michael Brown

IPO Date

2018-07-13

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

CH

Market Metrics

Open

$0.12

Prev. Close

$0.10

Day Low

$0.10

Day High

$0.12

52W Low

$0.07

52W High

$2.14

Market Cap

$0.01B

Volume

8.23M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.4%

Avg Negative

1.8%

Avg Neutral

67.8%

News Feed

OBSV Stock Increases Over 42% Intraday: Why It Happened

Pulse2·7/27/2021·↑ positive

ObsEva to Present Ebopiprant (OBE022) Data at the Society for Reproductive Investigation 68th Annual Meeting

GlobeNewsWire·7/2/2021·↑ positive

ObsEva Presents Clinical Data on Open-Label Pilot Study of Yselty® (linzagolix) for the Treatment of Severe Adenomyosis at ESHRE Virtual 37th Annual Meeting

GlobeNewsWire·6/30/2021·↑ positive

ObsEva To Present Data on Two Clinical Development Programs at ESHRE Virtual 37th Annual Meeting

GlobeNewsWire·6/24/2021·↑ positive

ObsEva Presents PROLONG Phase 2a Proof-of-Concept Data on Ebopiprant (OBE022) for the Treatment of Spontaneous Preterm Labor at the RCOG Virtual World Congress 2021

GlobeNewsWire·6/10/2021·↑ positive

ObsEva Announces Oral Presentation at the RCOG Virtual World Congress 2021

GlobeNewsWire·6/2/2021·↑ positive

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2021 Annual General Meeting held on May 28, 2021

GlobeNewsWire·5/31/2021·↑ positive

ObsEva Announces Proposed Changes to the Composition of its Board of Directors

GlobeNewsWire·5/25/2021·↑ positive

ObsEva Announces Final Results from the Phase 3 PRIMROSE Program of Yselty® (linzagolix) for the Treatment of Uterine Fibroids

GlobeNewsWire·5/20/2021·↑ positive

ObsEva Announces First Quarter 2021 Financial Results and Business Update

GlobeNewsWire·5/6/2021·↓ negative